Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
178.64B
Market cap178.64B
Price-Earnings ratio
27.85
Price-Earnings ratio27.85
Dividend yield
2.32%
Dividend yield2.32%
Average volume
8.91M
Average volume8.91M
High today
$103.99
High today$103.99
Low today
$101.92
Low today$101.92
Open price
$103.09
Open price$103.09
Volume
1.45M
Volume1.45M
52 Week high
$139.06
52 Week high$139.06
52 Week low
$100.88
52 Week low$100.88

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $102.57. The company's market cap stands at 178.64B, with a P/E ratio of 27.85 and a dividend yield of 2.3%.

On 2026-04-09, Abbott(ABT) stock moved within a range of $101.92 to $103.99. With shares now at $102.57, the stock is trading +0.6% above its intraday low and -1.4% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 1.45M, versus its average volume of 8.91M.

The stock's 52-week range extends from a low of $100.88 to a high of $139.06.

The stock's 52-week range extends from a low of $100.88 to a high of $139.06.

ABT News

Simply Wall St 14h
Assessing Abbott Laboratories Valuation After Precision Oncology Integration With Flatiron Health

Abbott Laboratories (ABT) is back in focus after announcing that its Precision Oncology test portfolio will be integrated into Flatiron Health’s OncoEMR platfor...

Assessing Abbott Laboratories Valuation After Precision Oncology Integration With Flatiron Health
Nasdaq 3d
S&P 500 Analyst Moves: ABT

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Abbott Laboratories is now the #79 an...

S&P 500 Analyst Moves: ABT
Nasdaq 3d
Abbott Laboratories Takes Over #44 Spot From Palo Alto Networks

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Abbott Laboratories (Symbol: ABT) has taken over th...

Abbott Laboratories Takes Over #44 Spot From Palo Alto Networks

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
25%
Sell
0%

More ABT News

Simply Wall St 6d
What Abbott Laboratories's Oncology Test Integration Into OncoEMR Means For Shareholders

Abbott and Flatiron Health recently integrated Abbott's Precision Oncology portfolio into Flatiron’s OncoEMR platform, enabling digital ordering and result deli...

What Abbott Laboratories's Oncology Test Integration Into OncoEMR Means For Shareholders

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.